{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:23:19Z","timestamp":1778181799449,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Focal segmental glomerulosclerosis (FSGS) is a frequent glomerular disease, and is the common cause of nephrotic syndrome. However, there is no validated diagnostic blood biomarker for FSGS. Here, we performed a real-time PCR-based high-throughput miRNA profiling to identify the plasma signature for FSGS. We found four miRNAs (miR-17, miR-451, miR-106a, and miR-19b) were significantly downregulated in the plasma of FSGS patients (<jats:italic>n<\/jats:italic>\u2009=\u200997) compared with healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u2009124) in the training, validation, and blinded-test phases. The miRNA panel produced an AUC value of 0.82, and was associated with FSGS severity and histologic classification. A three-miRNA panel, including miR-17, miR-451, and miR-106a was related to FSGS remission. Furthermore, the downregulation of plasma-miRNA signature was not detected in disease controls (<jats:italic>n<\/jats:italic>\u2009=\u2009119) such as IgA nephropathy (IgAN), mesangial proliferative glomerulonephritis (MSPGN), and membranous nephropathy (MN), and the miRNA panel discriminated between FSGS and disease controls. Pathway analysis showed that the four-miRNA panel may cooperatively regulate the pathways involved in the development of FSGS, such as apoptosis. We identified that phosphatase and tensin homolog (PTEN), Bcl-2-like protein 11 (BCL2L11), and chemokine (C-X-C motif) ligand 14 (CXCL14) were targets of miR-106a in human podocyte. Additionally, miR-106a overexpression suppressed podocyte apoptosis in vitro and the downregulation of four-miRNA panel probably resulted in the enhanced apoptosis in podocyte during FSGS development. Taken together, our data show that the plasma-miRNA panel is a potential independent diagnostic and prognostic factor for FSGS. Above miRNAs are involved in FSGS pathogenesis through regulating podocyte apoptosis.<\/jats:p>","DOI":"10.1038\/s41419-018-0569-y","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T08:41:45Z","timestamp":1525941705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Bin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Fei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Ming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"569_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/snep.2003.50025","volume":"23","author":"C Kitiyakara","year":"2003","unstructured":"Kitiyakara, C., Kopp, J. B. & Eggers, P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin. Nephrol. 23, 172\u2013182 (2003).","journal-title":"Semin. Nephrol."},{"key":"569_CR2","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D\u2019Agati","year":"2011","unstructured":"D\u2019Agati, V. D., Kaskel, F. J. & Falk, R. J. Focal segmental glomerulosclerosis. N. Engl. J. Med. 365, 2398\u20132411 (2011).","journal-title":"N. Engl. J. Med."},{"key":"569_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"569_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm.3142","volume":"19","author":"CA Gebeshuber","year":"2013","unstructured":"Gebeshuber, C. A. et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat. Med. 19, 481\u2013487 (2013).","journal-title":"Nat. Med."},{"key":"569_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1681\/ASN.2014020190","volume":"26","author":"L Kietzmann","year":"2015","unstructured":"Kietzmann, L. et al. MicroRNA-193a regulates the transdifferentiation of human parietal epithelial cells toward a podocyte phenotype. J. Am. Soc. Nephrol. 26, 1389\u20131401 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1681\/ASN.2012111101","volume":"25","author":"J Wu","year":"2014","unstructured":"Wu, J. et al. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J. Am. Soc. Nephrol. 25, 92\u2013104 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"569_CR7","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI81061","volume":"125","author":"J Wu","year":"2015","unstructured":"Wu, J. et al. MicroRNA-30 family members regulate calcium\/calcineurin signaling in podocytes. J. Clin. Invest. 125, 4091\u20134106 (2015).","journal-title":"J. Clin. Invest."},{"key":"569_CR8","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513\u201310518 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"MA Cortez","year":"2011","unstructured":"Cortez, M. A. et al. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8, 467\u2013477 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"569_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1470-2045(15)00048-0","volume":"16","author":"XJ Lin","year":"2015","unstructured":"Lin, X. J. et al. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lancet Oncol. 16, 804\u2013815 (2015).","journal-title":"Lancet Oncol."},{"key":"569_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtlscherer","year":"2010","unstructured":"Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677\u2013684 (2010).","journal-title":"Circ. Res."},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-6143.2012.04313.x","volume":"13","author":"VR Mas","year":"2013","unstructured":"Mas, V. R., Dumur, C. I., Scian, M. J., Gehrau, R. C. & Maluf, D. G. MicroRNAs as biomarkers in solid organ transplantation. Am. J. Transplant. 13, 11\u201319 (2013).","journal-title":"Am. J. Transplant."},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"e54662","DOI":"10.1371\/journal.pone.0054662","volume":"8","author":"C Argyropoulos","year":"2013","unstructured":"Argyropoulos, C. et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PloS ONE 8, e54662 (2013).","journal-title":"PloS ONE"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrneph.2014.50","volume":"10","author":"CC Szeto","year":"2014","unstructured":"Szeto, C. C. & Li, P. K. MicroRNAs in IgA nephropathy. Nat. Rev. Nephrol. 10, 249\u2013256 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"569_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep12644","volume":"5","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. Up-regulation of serum MiR-130b-3p level is associated with renal damage in early lupus nephritis. Sci. Rep. 5, 12644 (2015).","journal-title":"Sci. Rep."},{"key":"569_CR16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/or.2016.5010","volume":"36","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells. Oncol. Rep. 36, 2135\u20132141 (2016).","journal-title":"Oncol. Rep."},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","volume":"65","author":"C Zhang","year":"2015","unstructured":"Zhang, C. et al. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis. Am. J. Kidney Dis. 65, 223\u2013232 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"569_CR18","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2215\/CJN.00430111","volume":"6","author":"JM Lorenzen","year":"2011","unstructured":"Lorenzen, J. M. et al. Circulating miR-210 predicts survivaal in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 1540\u20131546 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"569_CR19","doi-asserted-by":"publisher","first-page":"e58014","DOI":"10.1371\/journal.pone.0058014","volume":"8","author":"F Glowacki","year":"2013","unstructured":"Glowacki, F. et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PloS ONE 8, e58014 (2013).","journal-title":"PloS ONE"},{"key":"569_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1373\/clinchem.2012.195297","volume":"59","author":"Y Luo","year":"2013","unstructured":"Luo, Y. et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 59, 658\u2013666 (2013).","journal-title":"Clin. Chem."},{"key":"569_CR21","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1681\/ASN.2013040390","volume":"25","author":"AK Marrone","year":"2014","unstructured":"Marrone, A. K. et al. MicroRNA-17~92 is required for nephrogenesis and renal function. J. Am. Soc. Nephrol. 25, 1440\u20131452 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.febslet.2011.07.042","volume":"586","author":"Z Zhang","year":"2012","unstructured":"Zhang, Z. et al. MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 586, 20\u201326 (2012).","journal-title":"FEBS Lett."},{"key":"569_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1089\/nat.2013.0438","volume":"23","author":"T Kaucsar","year":"2013","unstructured":"Kaucsar, T. et al. Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. Nucleic Acid. Ther. 23, 344\u2013354 (2013).","journal-title":"Nucleic Acid. Ther."},{"key":"569_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep15132","volume":"5","author":"Y Tang","year":"2015","unstructured":"Tang, Y. et al. The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease. Sci. Rep. 5, 15132 (2015).","journal-title":"Sci. Rep."},{"key":"569_CR25","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/emboj.2009.214","volume":"28","author":"HL Yan","year":"2009","unstructured":"Yan, H. L. et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28, 2719\u20132732 (2009).","journal-title":"EMBO J."},{"key":"569_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mc.21899","volume":"52","author":"Z Wang","year":"2013","unstructured":"Wang, Z. et al. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol. Carcinog. 52, 634\u2013646 (2013).","journal-title":"Mol. Carcinog."},{"key":"569_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000333809","volume":"34","author":"YQ Chen","year":"2011","unstructured":"Chen, Y. Q. et al. MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency. Am. J. Nephrol. 34, 549\u2013559 (2011).","journal-title":"Am. J. Nephrol."},{"key":"569_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0898-6568(01)00234-0","volume":"14","author":"NR Leslie","year":"2002","unstructured":"Leslie, N. R. & Downes, C. P. PTEN: The down side of PI 3-kinase signalling. Cell. Signal. 14, 285\u2013295 (2002).","journal-title":"Cell. Signal."},{"issue":"Suppl 1","key":"569_CR29","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/onc.2009.39","volume":"27","author":"E Lomonosova","year":"2008","unstructured":"Lomonosova, E. & Chinnadurai, G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27(Suppl 1), S2\u2013S19 (2008).","journal-title":"Oncogene"},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1159\/000106775","volume":"107","author":"MR Bennett","year":"2007","unstructured":"Bennett, M. R. et al. Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp. Nephrol. 107, e30\u2013e40 (2007).","journal-title":"Nephron Exp. Nephrol."},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.4049\/jimmunol.168.12.6244","volume":"168","author":"TB Huber","year":"2002","unstructured":"Huber, T. B. et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J. Immunol. 168, 6244\u20136252 (2002).","journal-title":"J. Immunol."},{"key":"569_CR32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630\u2013638 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"e41629","DOI":"10.1371\/journal.pone.0041629","volume":"7","author":"BS Li","year":"2012","unstructured":"Li, B. S. et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PloS ONE 7, e41629 (2012).","journal-title":"PloS ONE"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"e106049","DOI":"10.1371\/journal.pone.0106049","volume":"9","author":"ED Zhu","year":"2014","unstructured":"Zhu, E. D. et al. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1. PloS ONE 9, e106049 (2014).","journal-title":"PloS ONE"},{"key":"569_CR35","doi-asserted-by":"publisher","first-page":"e1623","DOI":"10.1038\/cddis.2014.573","volume":"6","author":"QF Zuo","year":"2015","unstructured":"Zuo, Q. F. et al. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. Cell Death Dis. 6, e1623 (2015).","journal-title":"Cell Death Dis."},{"key":"569_CR36","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1182\/blood-2013-06-510586","volume":"122","author":"B Xiao","year":"2013","unstructured":"Xiao, B. et al. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood 122, 3365\u20133375 (2013).","journal-title":"Blood"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0569-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0569-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:59:33Z","timestamp":1671537573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0569-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0569-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"533"}}